Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS
US8920812B2 · kind B2 · utility
5Cited by
2References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 3, 2010 |
| Grant date | Dec 30, 2014 |
| Priority date | — |
| Expiry date | Mar 17, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18534
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus GAG-based virus-like particles (VLPs). The present invention also includes methods of making and using such chimeric VLPs. In certain embodiments, the GAG polypeptide of the chimeric VLPs comprises an HIV or ALV GAG polypeptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.